基于生物材料的响应性纳米药物用于向固体瘤微环境.
Konstantinos Avgoustakis1,2, Athina Angelopoulou3
1Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Pharmaceutics
|February 24, 2024
概括
响应性纳米药物利用生物材料向固体瘤微环境 (TME). 这些先进的疗法克服了TME的挑战,提高了药物输送和抗癌效果,改善了患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 生物材料科学 生物材料科学
背景情况:
- 固体瘤具有复杂的,代谢活跃的微环境 (TME),影响治疗疗效.
- 在TME中的挑战包括异常的血管系统,密集的流层,缺氧和酸性pH值,阻碍药物输送.
- 纳米药物通过针对特定的TME特征来提供潜在的解决方案,以提高积累和透.
研究的目的:
- 审查对响应固体瘤微环境 (TME) 的纳米药物向机制.
- 探索基于生物材料的纳米药物如何利用或克服TME障碍.
- 用响应性纳米药物突出结合疗法和免疫疗法的进展.
主要方法:
- 针对瘤微环境 (TME) 的纳米医学策略的文献综述.
- 基于生物材料的纳米药物的分析,设计用于TME响应向.
- 对实体瘤中纳米医学应用的临床前和临床研究的审查.
主要成果:
- 响应性纳米药物表明改善了部位特异性和瘤透.
- 基于生物材料的纳米药物在提高治疗疗效和减少副作用方面表现有前途.
- 针对TME特征和免疫重编程是先进癌症治疗的关键策略.
结论:
- 使用生物材料的响应性纳米药物是克服TME挑战的有效工具.
- 这些系统显著提升了结合疗法和固体瘤免疫疗法.
- 进一步的开发有望提高抗癌有效性和患者的治疗结果.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K